Table of Contents Table of Contents
Previous Page  19 / 60 Next Page
Information
Show Menu
Previous Page 19 / 60 Next Page
Page Background

17

PROGRAMME & EXHIBITION GUIDE |

SCIENTIFIC PROGRAMME

Poster discussion session

14:00 - 15:30

Chair: J. Hess (Germany)

FDG based dose painting in head and neck cancer: preliminary results of a

phase I trial

J.H. Rasmussen (Denmark), I.R. Vogelius, B.M. Fischer, M.C. Aznar,

A.B. Gothelf, J. Friborg, C.A. Kristensen, S.M. Bentzen, L. Specht

PD-028

Temporal stability and reproducibility of FDG-PET-based dose painting

targets in head and neck cancer

I. Vogelius (Denmark), J.H. Rasmussen, B.M. Fischer, M.C. Aznar, A. Loft,

C.B. Christensen, J. Friborg, C.A. Kristensen, L. Specht

PD-029

The clinical relevance of standardised optic pathway delineation in radio-

therapy treatment planning

C. De Groot (The Netherlands), R.J.H.M. Steenbakkers, B. Dorgelo,

W.J. Japing, J.A. Langendijk, H.P. Bijl

PD-030

14:00 Discussant: V. Grégoire (Belgium)

Video-assisted minimally invasive surgery in patients with thyroid tumours

A. Polyakov (Russian Federation), F. Sevrukov, M. Ratushnyy, O. Matorin,

M. Filushin, V. Vasiliev, I. Rebrikova, A. Panaseikin, N. Babaskina

PD-031

Sk(C)ip into the mouth

Y. He (China), Z. Zhang, C. Zhang

PD-032

Value of lymphatic mapping SPECT/CT for sentinel node biopsy in 37

patients with T1-T2N0 oral cancer

G. Poissonnet (France), E. Berta, M.J. Ouvrier, A. Sudaka, O. Dassonville,

A. Bozec, D. Culié

PD-033

14:22 Discussant: C. Simon (Switzerland)

Data from Pet Neck and GSK trials: Regional and geographic variability in

HPV-associated oropharyngeal cancer

H. Mehanna (United Kingdom), M. Robinson, N. Powell, V. Paleri, A. Hartley,

L. Fresco, H. Al-Booz, E. Junor, S. Roberts, K. Harrington

PD-034